Clinical Trials in Norway — Country Dashboard | 665 EU Studies

Filter these 665 trials by condition, phase, sponsor and more.

Open in Search →

665 Registered trials

303 Recruiting

299 Completed trials

219 Sponsors active

122 Research sites

Phase III

Phase II

Phase III: 316 Phase II/III: 37 Phase II: 180 Phase I/II: 37 Phase III/IV: 6 Phase IV: 53 Phase I: 9 Phase I (Other): 19 Phase I (FiH): 7 Other: 1

Oversight events in trials active here:

49 serious breaches 168 temporary halts 11 urgent safety measures 19 unexpected events 25 corrective measures across 89 trials

View oversight register →

Top conditions

Non-small cell lung cancer 11 Crohn's disease 7 Glioblastoma 6 Plasma cell myeloma refractory 6 Colitis ulcerative 6 Ovarian cancer 5 Prostate cancer metastatic 5 Fabry´s disease 5 Myelodysplastic syndrome 4 Myasthenia gravis 4 Squamous cell carcinoma of head and neck 4 Hepatocellular carcinoma 4

Top sponsors

Oslo University Hospital HF 75 Merck Sharp & Dohme LLC 43 Helse Bergen HF 26 Boehringer Ingelheim International GmbH 21 AstraZeneca AB 18 Boehringer Ingelheim Espana S.A. 18 Sanofi-Aventis Recherche & Developpement 18 Novartis Pharma AG 17 St. Olavs Hospital HF 17 Celgene Corp. 12 Glaxosmithkline Research & Development Limited 12 Janssen - Cilag International 12

Cities with most trials

All 59 cities →

All trials

665 total

Feasibility study of Neo-adjuvant (before surgery) versus Adjuvant (after surgery) chemotherapy in Upper Tract Urothelial Carcinoma Under evaluation

2024-514991-41-01 Phase II Upper Tract Urothelial Carcinoma. Upper urinary tract transi… European Uro-Oncology Group Stichting
Atorvastatin in episodic migraine Not authorised

2022-502176-23-00 Phase II Migraine St. Olavs Hospital HF
Atorvastatin in chronic migraine (StainMigChronic) Not authorised

2022-502177-42-01 Phase II Chronic migraine St. Olavs Hospital HF
A study to assess the efficacy and safety of OATD-01 for the treatment of active pulmonary sarcoidosis. Not authorised

2023-506642-23-00 Phase II Active Pulmonary Sarcoidosis Molecure S.A.
A Study on the Immune Response and Safety of the Second Dose of an Investigational Chickenpox Vaccine when Given to Healthy Children 3 Month… Not authorised

2024-516635-27-00 Phase III Varicella GlaxoSmithKline Biologicals
A clinical study of MK-7240 for the treatment of ulcerative colitis (MK-7240-001) Unknown

2025-523766-25-00 Phase III Ulcerative colitis Merck Sharp & Dohme LLC
IVIGSeN Pending

2022-501717-31-00 Phase II/III Idiopathic painful small fiber neuropathy or sensory neurono… Sorlandet Sykehus HF
The ALPINE trial: a phase 1-2 study of intra-arterial [177Lu]Lu-PSMA-I&T for progressive or recurrent intracranial adult type diffuse gliom… Pending

2023-504696-24-00 Phase I (FiH) Glioma (diffuse astrocytoma, oligodendroglioma or glioblasto… Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
A Clinical Trial Evaluating the Efficacy of Valganciclovir in Glioblastoma Patients Pending

2023-504846-73-01 Phase II Glioblstoma WHO grade IV Karolinska Institutet
Treatment of frontal fibrosing alopecia with microneedling and photodynamic therapy Pending

2023-506974-11-00 Phase II Frontal fibrosing alopecia (FFA) Oslo University Hospital HF
Pain Relief at Screening for Retinopathy of Prematurity - The PROPER study Pending

2023-507975-23-01 Phase II Retinopathy of prematurity St. Olavs Hospital HF
Phase 2 randomised study of Radspherin® in patients with peritoneal carcinomatosis from colorectal carcinoma after cytoreductive surgery (CR… Pending

2023-508496-37-00 Phase II Carcinomatosis of peritoneal cavity Oncoinvent Solutions AS
IntReALL BCP 2020 – International Study for Treatment of Childhood Relapsed Precursor B-cell ALL 2020 Pending

2023-509392-17-00 Phase III Relapsed Acute Lymphoblastic Leukemia (ALL) Charite Universitaetsmedizin Berlin KöR
An exploratory phase II study aimed to detect long term changes in volume of port-wine macrocheilia and color of port-wine stain in patients… Pending

2024-511937-37-01 Phase II Vascular malfomation Oslo University Hospital HF
Intranasal oxytocin in youth with autism Pending

2024-512387-56-00 Phase II Autism spectrum disorder Oslo University Hospital HF
ALASCCA-A randomized double-blind placebo-controlled study with ASA treatment in colorectal cancer patients with mutations in the PI3K signa… Pending

2024-513778-23-00 Phase III Colon and rectal cancer tumor stage II-III, tumor with somat… Karolinska Institutet
Vi-Siblin for LARS: A randomized, controlled trial. Pending

2024-514541-11-00 Phase II Low anterior resection syndrome after low anterior resection… Sykehuset Telemark HF
The CORINTH Trial: Study of Checkpoint Inhibitor Pembrolizumab plus standard chemoradiation in anal cancer Pending

2024-515369-33-00 Anal cancer Cardiff University
BEACON 2: A Multi-Arm, Multi-Stage Platform Trial For Relapsed Neuroblastoma Pending

2024-516115-24-00 Phase I/II High risk relapsed neuroblastoma (relapsed or progressed aft… The University Of Birmingham
Oxytocin & benzodiazepines Pending

2024-516262-11-00 Phase II Benzodiazepine dependence (F13.2) St. Olavs Hospital HF
A multicenter, randomized, open-label, blinded-assessor, phase 4 study in patients with early rheumatoid arthritis to compare active convent… Pending

2024-516723-14-00 Phase IV Rheumatoid Arthritis Karolinska Institutet
ZAMBA: Zoledronic Acid for Modic Back Pain. Pending

2024-517345-14-00 Phase III Low Back Pain Oslo University Hospital HF
Study to Investigate the Efficacy, Safety, and Tolerability of Intravenous Gammagard Liquid (Immune Globulin Infusion, 10%) for Primary Infe… Pending

2024-518420-80-00 Phase III Primary infection prophylaxis for secondary immunodeficiency… Takeda Development Center Americas Inc.
68Ga/177Lu-PSMA theranostics in recurrent grade 3 and grade 4 glioma Pending

2024-518495-31-00 Phase II Recurrent grade 3 and grade 4 glioma Norwegian University Of Science And Technolology

Showing 1–24 of 665 trials

← All countries